Hepatic glucose uptake is increased in association with elevated serum c-glutamyl transpeptidase and triglyceride

Digestive Diseases and Sciences

Volumn 59, Issue 3, 2014, Pages 607-613

  Hong, Sun Pyo ^a   Noh, Tae Soo ^a   Moon, Seung Hwan ^a   Cho, Young Seok ^a   Lee, Eun Jeong ^a   Choi, Joon Young ^a   Kim, Byung Tae ^a   Lee, Kyung Han ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

C Glutamyl transferase; Fatty liver disease; Glucose; Triglyceride

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; FLUORODEOXYGLUCOSE F 18; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADULT; ALCOHOLIC FATTY LIVER; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG UPTAKE; ECHOGRAPHY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEPATITIS; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FLUORODEOXYGLUCOSE F18; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LINEAR MODELS; LIVER; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TRIGLYCERIDES;

EID: 84896700622     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2957-6     Document Type: Article

References (27)

1. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. Can Med Assoc J. 2005;172:899-905.
2. Irie M, Suzuki N, Sohda T, et al. Hepatic expression of gammaglutamyltranspeptidase in the human liver of patients with alcoholic liver disease. Hepatol Res. 2007;37:966-973.
3. Marchesini G, Avagnina S, Barantani EG, et al. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest. 2005;28:333-339.
4. McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59:1265-1269.
5. Munoz LE, Cordero P, Torres L, Sauceda AY, Flores JP, Segura JJ. Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis. Ann Hepatol. 2009;8:123-128.
6. Tahan V, Canbakan B, Balci H, et al. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology. 2008;55:1433-1438.
7. Thamer C, Tschritter O, Haap M, et al. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm Metab Res. 2005;37:246-251.
8. Kotronen A, Westerbacka J,BergholmR, Pietilainen KH, Yki-Jarvinen H. Liver fat in the metabolic syndrome. J Clin Endocrinol Metab. 2007;92:3490-3497.
9. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes. 2001;50: 1844-1850.
10. Marchesini G, Marzocchi R. Metabolic syndrome and NASH. Clin Liver Dis. 2007;11:105-117.
11. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: Old questions and new insights. Science. 2011;332:1519-1523.
12. Kashyap SR, Diab DL, Baker AR, et al. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. Obesity (Silver Spring). 2009;17:1696-1701.
13. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics. 2005;25:1357-1368.
14. Ceulemans G, Ilsen B, Verdries D, de Mey J, Everaert H. Focal eosinophilic hepatitis simulating a solitary metastatic lesion on FDG-PET/CT in a patient with history of head and neck cancer. JBR-BTR. 2011;94:94.
15. Nakahara T, Takagi Y, Takemasa K, et al. Dose-related fluorodeoxyglucose uptake in acute radiation-induced hepatitis. Eur J Gastroenterol Hepatol. 2008;20:1040-1044.
16. Bural GG, Torigian DA, Burke A, et al. Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MRimaging: A novel concept. Mol Imaging Biol. 2010;12:233-239.
17. Abikhzer G, Alabed YZ, Azoulay L, Assayag J, Rush C. Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT. Am J Roentgenol (AJR). 2011;196:176-180.
18. Borra R, Lautamaki R, Parkkola R, et al. Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus. Metabolism. 2008;57:1445-1451.
19. Lin CY, Lin WY, Lin CC, Shih CM, Jeng LB, Kao CH. The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET. Clin Imaging. 2011;35:437-441.
20. Abele JT, Fung CI. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values. Radiology. 2010;254:917-924.
21. Dostbil Z, Varoglu E, Serdengecti M, Kaya B, Onder H, Sari O. Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDGPET/CT. RevEsp Med Nucl Image Mol. 2013;32:156-161.
22. Adams LA, Lymp JF, Sauver J, et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology. 2005;129:113-121.
23. Vallabhajosula S. 18F-labeled positron emission tomographic radiopharmaceuticals in oncology: An overview of radiochemistry and mechanisms of tumor localization. Semin Nucl Med. 2007;37:400-419.
24. Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med. 2012;52:59-69.
25. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001;38:263-355.
26. Irie M, Sohda T, Iwata K, et al. Levels of the oxidative stress marker gamma-glutamyltranspeptidase at different stages of nonalcoholic fatty liver disease. J Int Med Res. 2012;40:924-933.
27. Ma X, Holalkere NS, Kambadakone RA, Mino-Kenudson M, Hahn PF, SahaniDV. Imaging-based quantification of hepatic fat: Methods and clinical applications. Radiographics. 2009;29:1253-1277.